527 related articles for article (PubMed ID: 34021229)
1. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study.
Ikeda S; Misumi T; Izumi S; Sakamoto K; Nishimura N; Ro S; Fukunaga K; Okamori S; Tachikawa N; Miyata N; Shinkai M; Shinoda M; Miyazaki Y; Iijima Y; Izumo T; Inomata M; Okamoto M; Yamaguchi T; Iwabuchi K; Masuda M; Takoi H; Oyamada Y; Fujitani S; Mineshita M; Ishii H; Nakagawa A; Yamaguchi N; Hibino M; Tsushima K; Nagai T; Ishikawa S; Ishikawa N; Kondoh Y; Yamazaki Y; Gocho K; Nishizawa T; Tsuzuku A; Yagi K; Shindo Y; Takeda Y; Yamanaka T; Ogura T
Sci Rep; 2021 May; 11(1):10727. PubMed ID: 34021229
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
[TBL] [Abstract][Full Text] [Related]
4. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.
Liu Z; Li X; Fan G; Zhou F; Wang Y; Huang L; Yu J; Yang L; Shang L; Xie K; Xu J; Huang Z; Gu X; Li H; Zhang Y; Wang Y; Huang Z; Cao B
Clin Microbiol Infect; 2021 Jan; 27(1):112-117. PubMed ID: 33007478
[TBL] [Abstract][Full Text] [Related]
5. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
[TBL] [Abstract][Full Text] [Related]
7. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
Hermine O; Mariette X; Tharaux PL; Resche-Rigon M; Porcher R; Ravaud P;
JAMA Intern Med; 2021 Jan; 181(1):32-40. PubMed ID: 33080017
[TBL] [Abstract][Full Text] [Related]
8. Effect of Corticosteroids on Mortality in Hospitalized COVID-19 Patients Not Receiving Invasive Mechanical Ventilation.
Fusina F; Albani F; Granato E; Meloni A; Rozzini R; Sabatini T; Stellini R; Terragnoli P; Rosano A; Abu Hilal M; Natalini G
Clin Pharmacol Ther; 2021 Jun; 109(6):1660-1667. PubMed ID: 33792037
[TBL] [Abstract][Full Text] [Related]
9. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
11. Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Diaz R; Orlandini A; Castellana N; Caccavo A; Corral P; Corral G; Chacón C; Lamelas P; Botto F; Díaz ML; Domínguez JM; Pascual A; Rovito C; Galatte A; Scarafia F; Sued O; Gutierrez O; Jolly SS; Miró JM; Eikelboom J; Loeb M; Maggioni AP; Bhatt DL; Yusuf S;
JAMA Netw Open; 2021 Dec; 4(12):e2141328. PubMed ID: 34964849
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
13. Steroids and mortality in non-critically ill COVID-19 patients: a propensity score-weighted study in a Chilean cohort.
Moreno A; Vargas C; Azocar F; Villarroel F; Cofré M; Oppliger H; Ríos F; Raijmakers M; Silva-Ayarza I; Beltrán C; Zamora F
Int J Infect Dis; 2021 Nov; 112():124-129. PubMed ID: 34547488
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America.
Yang JY; Parkins MD; Canakis A; Aroniadis OC; Yadav D; Dixon RE; Elmunzer BJ; Forbes N;
JAMA Netw Open; 2021 Jan; 4(1):e2035699. PubMed ID: 33507259
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial.
Ely EW; Ramanan AV; Kartman CE; de Bono S; Liao R; Piruzeli MLB; Goldman JD; Saraiva JFK; Chakladar S; Marconi VC;
Lancet Respir Med; 2022 Apr; 10(4):327-336. PubMed ID: 35123660
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry.
Amer M; Kamel AM; Bawazeer M; Maghrabi K; Butt A; Dahhan T; Kseibi E; Khurshid SM; Abujazar M; Alghunaim R; Rabee M; Abualkhair M; Al-Janoubi A; AlFirm AT; Gajic O; Walkey AJ; Mosier JM; Zabolotskikh IB; Gavidia OY; Teruel SY; Bernstein MA; Boman K; Kumar VK; Bansal V; Kashyap R;
Eur J Med Res; 2021 Oct; 26(1):117. PubMed ID: 34600589
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study.
Li Y; Meng Q; Rao X; Wang B; Zhang X; Dong F; Yu T; Li Z; Feng H; Zhang J; Chen X; Li H; Cheng Y; Hong X; Wang X; Yin Y; Zhang Z; Wang D
Crit Care; 2020 Dec; 24(1):698. PubMed ID: 33339536
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
19. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
Torres A; Motos A; Cillóniz C; Ceccato A; Fernández-Barat L; Gabarrús A; Bermejo-Martin J; Ferrer R; Riera J; Pérez-Arnal R; García-Gasulla D; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Almansa R; Menéndez R; Palomeque A; Villar RA; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Boado MV; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego E; García Garmendia JL; Gómez JM; Huerta A; García RNJ; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; López Messa J; Albaiceta GM; Nieto M; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Serra-Fortuny M; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Barbé F;
Intensive Care Med; 2022 Jul; 48(7):850-864. PubMed ID: 35727348
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]